The causes of the variability in clinical expression of sickle cell anemia (SCA) (SS) are poorly understood. Recently, we have shown that DNA polymorphisms flanking the beta(s)-gene and the number of alpha- globin genes define genotypic subsets of SCA are associated with strikingly different risks of overall vasocclusive disease severity as well as individual vasocclusive complications. Specific polymorphisms of the beta(s)-gene cluster are associated with differential levels of increased fetal hemoglobin and (G)gamma Hb F production which may in part explain the variability in the risk of sickle cell induced end organ damage. In the present proposal, we seek to build upon and extend these observations. We hypothesize that the polymorphisms of the beta(s)-gene cluster are consistently associated with different degrees of abnormality of red cell and other phenotypic parameters which contribute to vascular occlusion and, furthermore, that the combination of genotypic and phenotypic analysis will better predict clinical disease severity. The project has two main goals. First, we wish to determine whether the observed differences in vasocclusive disease severity characteristic of different genotypic subsets of SCA can be explained by differences in RBC and other phenotypic abnormalities thought to the relevant to the pathogenesis of vascular occlusion. Second, we wish to determine whether phenotypic analysis improves the predictive value of genotypic analysis for the risk of vasocclusive disease in SCA. These investigations should shed additional light on the pathogenesis of vascular occlusion in SCA. These investigations should shed additional light on the pathogenesis of vascular occlusion in SCA, as well as improve the prediction of clinical disease severity in the individual subject with SCA which could have important implications for treatment stratification.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Comprehensive Center (P60)
Project #
5P60HL048484-04
Application #
5213961
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1996
Total Cost
Indirect Cost
Rabai, M; Detterich, J A; Wenby, R B et al. (2014) Effects of ethanol on red blood cell rheological behavior. Clin Hemorheol Microcirc 56:87-99
Castellini, Michael; Elsner, Robert; Baskurt, Oguz K et al. (2006) Blood rheology of Weddell seals and bowhead whales. Biorheology 43:57-69
Johnson, Cage S (2005) Arterial blood pressure and hyperviscosity in sickle cell disease. Hematol Oncol Clin North Am 19:827-37, vi
Senturk, Umit K; Yalcin, Ozlem; Gunduz, Filiz et al. (2005) Effect of antioxidant vitamin treatment on the time course of hematological and hemorheological alterations after an exhausting exercise episode in human subjects. J Appl Physiol 98:1272-9
Johnson, Cage S (2005) The acute chest syndrome. Hematol Oncol Clin North Am 19:857-79, vi-vii
Baskurt, Oguz K; Yalcin, Ozlem; Meiselman, Herbert J (2004) Hemorheology and vascular control mechanisms. Clin Hemorheol Microcirc 30:169-78
Armstrong, J K; Wenby, R B; Meiselman, H J et al. (2004) The hydrodynamic radii of macromolecules and their effect on red blood cell aggregation. Biophys J 87:4259-70
Baskurt, Oguz K; Yalcin, Ozlem; Ozdem, Sadi et al. (2004) Modulation of endothelial nitric oxide synthase expression by red blood cell aggregation. Am J Physiol Heart Circ Physiol 286:H222-9
Batra, Sandeep; Perelman, Natalya; Luck, Lori R et al. (2003) Pediatric tumor cells express erythropoietin and a functional erythropoietin receptor that promotes angiogenesis and tumor cell survival. Lab Invest 83:1477-87
Chong-Martinez, B; Buchanan, T A; Wenby, R B et al. (2003) Decreased red blood cell aggregation subsequent to improved glycaemic control in Type 2 diabetes mellitus. Diabet Med 20:301-6

Showing the most recent 10 out of 66 publications